Renewal of the Interventions Testing Program (U01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Deadline: Jun 19, 2023

Grant amount: Up to US $15,000,000

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization. 

This Funding Opportunity Announcement (FOA) calls for the renewal and further development of the Interventions Testing Program (ITP). The ITP tests potential intervention strategies that may delay aging in mammals under standardized conditions.The interventions' effects on aging are measured by lifespan extension and/or delayed onset/severity of late life pathologies. The ITP uses lifespan as a primary outcome. Secondary outcomes currently include geropathology assessment at 22 months of age and pathology at time of death, functional phenotypes (e.g., measures of strength) and measurements of animal vitals (e.g., weight) at intervals across the lifespan.

Direct costs for awards may not exceed $3 million per year for the entire consortium. The maximum project period is 5 years.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.